Literature DB >> 29294006

Diurnal Variation in PDK4 Expression Is Associated With Plasma Free Fatty Acid Availability in People.

Shintaro Yamaguchi1, Anna C Moseley1, Paloma Almeda-Valdes1, Kelly L Stromsdorfer1, Michael P Franczyk1, Adewole L Okunade1, Bruce W Patterson1, Samuel Klein1, Jun Yoshino1.   

Abstract

Context: Many biological pathways involved in regulating substrate metabolism display rhythmic oscillation patterns. In rodents, clock genes regulate circadian rhythms of metabolic genes and substrate metabolism. However, the interrelationships among substrate metabolism, metabolic genes, and clock genes have not been fully explored in people. Objective: We tested the hypothesis that the diurnal expression pattern of pyruvate dehydrogenase kinase 4 (PDK4), a key metabolic enzyme involved in fuel switching between glucose and free fatty acids (FFAs), is associated with plasma FFA concentration and clock genes. Design and
Methods: We analyzed peripheral blood mononuclear cells (PBMCs), subcutaneous adipose tissue, and plasma samples obtained serially during 24 hours from metabolically healthy women (n = 10) and evaluated the interrelationships among PDK4, plasma FFA, and clock genes. We also determined the potential mechanisms responsible for PDK4 transcriptional regulation by using primary human PBMCs and adipocytes.
Results: We found that PDK4 diurnal expression patterns were similar in PBMCs and adipose tissue (ρ = 0.84, P < 0.001). The diurnal variation in PBMC PDK4 expression correlated more strongly with plasma FFA and insulin (ρ = 0.86 and 0.63, respectively, both P < 0.001) concentrations than clock genes. Data obtained from primary culture experiments demonstrated that FFAs directly induced PDK4 gene expression, at least in part through activation of peroxisome proliferator-activated receptor α. Conclusions: Our results suggest that plasma FFA availability is an important regulator of diurnal expression patterns of PDK4, and we identify a novel interaction between plasma FFA and cellular diurnal rhythms in regulating substrate metabolism.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29294006      PMCID: PMC6283414          DOI: 10.1210/jc.2017-02230

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

Review 1.  Getting through to circadian oscillators: why use constant routines?

Authors:  Jeanne F Duffy; Derk-Jan Dijk
Journal:  J Biol Rhythms       Date:  2002-02       Impact factor: 3.182

2.  Circadian clock genes oscillate in human peripheral blood mononuclear cells.

Authors:  Diane B Boivin; Francine O James; Aibin Wu; Park F Cho-Park; Huabao Xiong; Zhong S Sun
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

3.  Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus.

Authors:  Sameer S Kulkarni; Firoozeh Salehzadeh; Tomas Fritz; Juleen R Zierath; Anna Krook; Megan E Osler
Journal:  Metabolism       Date:  2011-08-03       Impact factor: 8.694

4.  Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states.

Authors:  Young I Kim; Felix N Lee; Woo S Choi; Sarah Lee; Jang H Youn
Journal:  Diabetes       Date:  2006-08       Impact factor: 9.461

5.  Changes of Dietary Fat and Carbohydrate Content Alter Central and Peripheral Clock in Humans.

Authors:  Olga Pivovarova; Karsten Jürchott; Natalia Rudovich; Silke Hornemann; Lu Ye; Simona Möckel; Veronica Murahovschi; Katharina Kessler; Anne-Cathrin Seltmann; Christiane Maser-Gluth; Jeannine Mazuch; Michael Kruse; Andreas Busjahn; Achim Kramer; Andreas F H Pfeiffer
Journal:  J Clin Endocrinol Metab       Date:  2015-03-30       Impact factor: 5.958

Review 6.  Physiological links between circadian rhythms, metabolism and nutrition.

Authors:  Jonathan D Johnston
Journal:  Exp Physiol       Date:  2014-09       Impact factor: 2.969

7.  Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance.

Authors:  Jun Yoshino; Caterina Conte; Luigi Fontana; Bettina Mittendorfer; Shin-ichiro Imai; Kenneth B Schechtman; Charles Gu; Iris Kunz; Filippo Rossi Fanelli; Bruce W Patterson; Samuel Klein
Journal:  Cell Metab       Date:  2012-10-25       Impact factor: 27.287

8.  Pyruvate dehydrogenase activation and kinase expression in human skeletal muscle during fasting.

Authors:  Lawrence L Spriet; Rebecca J Tunstall; Matthew J Watt; Kate A Mehan; Mark Hargreaves; David Cameron-Smith
Journal:  J Appl Physiol (1985)       Date:  2004-02-13

9.  Adiponectin decreases pyruvate dehydrogenase kinase 4 gene expression in obese- and diabetic-derived myotubes.

Authors:  A J McAinch; D Cameron-Smith
Journal:  Diabetes Obes Metab       Date:  2009-07       Impact factor: 6.577

Review 10.  Circadian integration of metabolism and energetics.

Authors:  Joseph Bass; Joseph S Takahashi
Journal:  Science       Date:  2010-12-03       Impact factor: 47.728

View more
  4 in total

1.  Adipose Tissue CTGF Expression is Associated with Adiposity and Insulin Resistance in Humans.

Authors:  Jun Yoshino; Bruce W Patterson; Samuel Klein
Journal:  Obesity (Silver Spring)       Date:  2019-04-19       Impact factor: 5.002

2.  Percutaneous muscle biopsy-induced tissue injury causes local endoplasmic reticulum stress.

Authors:  Jun Yoshino; Paloma Almeda-Valdes; Anna C Moseley; Bettina Mittendorfer; Samuel Klein
Journal:  Physiol Rep       Date:  2018-04

3.  Removal of Epididymal Visceral Adipose Tissue Prevents Obesity-Induced Multi-organ Insulin Resistance in Male Mice.

Authors:  Michael P Franczyk; Mai He; Jun Yoshino
Journal:  J Endocr Soc       Date:  2021-02-20

4.  Co-expression network analysis predicts a key role of microRNAs in the adaptation of the porcine skeletal muscle to nutrient supply.

Authors:  Emilio Mármol-Sánchez; Yuliaxis Ramayo-Caldas; Raquel Quintanilla; Tainã Figueiredo Cardoso; Rayner González-Prendes; Joan Tibau; Marcel Amills
Journal:  J Anim Sci Biotechnol       Date:  2020-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.